Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Toxocara related peritonitis: A case report and review of literature.

Arslan F, Baysal NB, Aslan A, Simsek BC, Vahaboglu H.

Parasitol Int. 2019 Jul 4;73:101950. doi: 10.1016/j.parint.2019.101950. [Epub ahead of print]

PMID:
31279784
2.

Risk factors for noncatheter-related Candida bloodstream infections in intensive care units: A multicenter case-control study.

Arslan F, Caskurlu H, Sari S, Dal HC, Turan S, Sengel BE, Gul F, Yesilbag Z, Eren G, Temel S, Alp E, Gol Serin B, Kose S, Calik S, Tuncel ZT, Senbayrak S, Sari A, Karagoz G, Tomruk SG, Sen B, Hizarci B, Vahaboglu H.

Med Mycol. 2018 Nov 28. doi: 10.1093/mmy/myy127. [Epub ahead of print]

PMID:
30496520
3.

Clinical Presentation and Cranial MRI Findings of Listeria monocytogenes Encephalitis: A Literature Review of Case Series.

Arslan F, Ertan G, Emecen AN, Fillatre P, Mert A, Vahaboglu H.

Neurologist. 2018 Nov;23(6):198-203. doi: 10.1097/NRL.0000000000000212. Review.

PMID:
30379745
4.

Predictors of unfavorable outcome in neurosyphilis: Multicenter ID-IRI Study.

Ozturk-Engin D, Erdem H, Hasbun R, Wang SH, Tireli H, Tattevin P, Argemi X, Ouamara-Digue E, Gombos A, Lakatos B, Sırmatel F, Cag Y, Pekok AU, Senbayrak S, Balkan II, Gheno M, Uzun N, Kaya S, Cicek-Senturk G, Şengöz G, Tekin R, Çelen MK, Nayman-Alpat S, Ergen P, Şener A, Agalar C, Köse S, Inkaya AÇ, Kaptan F, Al-Majid F, Savasci U, Vahaboglu H.

Eur J Clin Microbiol Infect Dis. 2019 Jan;38(1):125-134. doi: 10.1007/s10096-018-3403-7. Epub 2018 Oct 27.

PMID:
30368740
5.

Comparison of universal prophylaxis and preemptive approach for cytomegalovirus associated outcome measures in renal transplant patients: A meta-analysis of available data.

Caskurlu H, Karadag FY, Arslan F, Cag Y, Vahaboglu H.

Transpl Infect Dis. 2019 Feb;21(1):e13016. doi: 10.1111/tid.13016. Epub 2018 Nov 9.

PMID:
30358045
6.

Development and validation of a modified quick SOFA scale for risk assessment in sepsis syndrome.

Cag Y, Karabay O, Sipahi OR, Aksoy F, Durmus G, Batirel A, Ak O, Kocak-Tufan Z, Atilla A, Piskin N, Akbas T, Erol S, Ozturk-Engin D, Caskurlu H, Onal U, Erdogan H, Demirel A, Dogru A, Harman R, Hamidi AA, Karasu D, Korkmaz F, Korkmaz P, Civelek Eser F, Onem Y, Cesur S, Salmanoglu M, Erdem İ, Diktas H, Vahaboglu H.

PLoS One. 2018 Sep 26;13(9):e0204608. doi: 10.1371/journal.pone.0204608. eCollection 2018.

7.

Changes in antimicrobial resistance and demographics of UTIs in pediatric patients in a single institution over a 6-year period.

Erol B, Culpan M, Caskurlu H, Sari U, Cag Y, Vahaboglu H, Özumut SH, Karaman MI, Caskurlu T.

J Pediatr Urol. 2018 Apr;14(2):176.e1-176.e5. doi: 10.1016/j.jpurol.2017.12.002. Epub 2018 Jan 9.

PMID:
29428362
8.

Central nervous system infections in the absence of cerebrospinal fluid pleocytosis.

Erdem H, Ozturk-Engin D, Cag Y, Senbayrak S, Inan A, Kazak E, Savasci U, Elaldi N, Vahaboglu H, Hasbun R; ID-IRI study group.

Int J Infect Dis. 2017 Dec;65:107-109. doi: 10.1016/j.ijid.2017.10.011. Epub 2017 Nov 10.

9.

A brief comment on vaccinations for opportunistic microorganisms.

Arslan F, Vahaboğlu H.

Crit Care. 2017 May 5;21(1):100. doi: 10.1186/s13054-017-1684-3. No abstract available.

10.

Resistance mechanisms.

Cag Y, Caskurlu H, Fan Y, Cao B, Vahaboglu H.

Ann Transl Med. 2016 Sep;4(17):326. Review.

11.

Tick-related facial cellulitis caused by Francisella tularensis.

Arslan F, Karagöz E, Zemheri E, Vahaboglu H, Mert A.

Infez Med. 2016 Jun 1;24(2):140-3.

12.

Managing atypical and typical herpetic central nervous system infections: results of a multinational study.

Cag Y, Erdem H, Leib S, Defres S, Kaya S, Larsen L, Poljak M, Ozturk-Engin D, Barsic B, Argemi X, Sørensen SM, Bohr AL, Tattevin P, Gunst JD, Baštáková L, Jereb M, Johansen IS, Karabay O, Pekok AU, Sipahi OR, Chehri M, Beraud G, Shehata G, Fontana R, Maresca M, Karsen H, Sengoz G, Sunbul M, Yilmaz G, Yilmaz H, Sharif-Yakan A, Kanj S, Parlak E, Pehlivanoglu F, Korkmaz F, Komur S, Kose S, Ulug M, Bolukcu S, Coskuner SA, Stahl JP, Ince N, Akkoyunlu Y, Halac G, Sahin-Horasan E, Tireli H, Kilicoglu G, Al-Mahdawi A, Nemli SA, Inan A, Senbayrak S, Vahaboglu H, Elaldi N.

Clin Microbiol Infect. 2016 Jun;22(6):568.e9-568.e17. doi: 10.1016/j.cmi.2016.03.027. Epub 2016 Apr 13.

13.

Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study.

Yilmaz M, Elaldi N, Balkan İİ, Arslan F, Batırel AA, Bakıcı MZ, Gozel MG, Alkan S, Çelik AD, Yetkin MA, Bodur H, Sınırtaş M, Akalın H, Altay FA, Şencan İ, Azak E, Gündeş S, Ceylan B, Öztürk R, Leblebicioglu H, Vahaboglu H, Mert A.

Ann Clin Microbiol Antimicrob. 2016 Feb 9;15:7. doi: 10.1186/s12941-016-0122-8.

14.

Antituberculosis drug resistance patterns in adults with tuberculous meningitis: results of haydarpasa-iv study.

Senbayrak S, Ozkutuk N, Erdem H, Johansen IS, Civljak R, Inal AS, Kayabas U, Kursun E, Elaldi N, Savic B, Simeon S, Yilmaz E, Dulovic O, Ozturk-Engin D, Ceran N, Lakatos B, Sipahi OR, Sunbul M, Yemisen M, Alabay S, Beovic B, Ulu-Kilic A, Cag Y, Catroux M, Inan A, Dragovac G, Deveci O, Tekin R, Gul HC, Sengoz G, Andre K, Harxhi A, Hansmann Y, Oncu S, Kose S, Oncul O, Parlak E, Sener A, Yilmaz G, Savasci U, Vahaboglu H.

Ann Clin Microbiol Antimicrob. 2015 Nov 4;14:47. doi: 10.1186/s12941-015-0107-z.

15.

Comparison of brucellar and tuberculous spondylodiscitis patients: results of the multicenter "Backbone-1 Study".

Erdem H, Elaldi N, Batirel A, Aliyu S, Sengoz G, Pehlivanoglu F, Ramosaco E, Gulsun S, Tekin R, Mete B, Balkan II, Sevgi DY, Giannitsioti E, Fragou A, Kaya S, Cetin B, Oktenoglu T, DoganCelik A, Karaca B, Horasan ES, Ulug M, Inan A, Kaya S, Arslanalp E, Ates-Guler S, Willke A, Senol S, Inan D, Guclu E, Tuncer-Ertem G, Meric-Koc M, Tasbakan M, Senbayrak S, Cicek-Senturk G, Sırmatel F, Ocal G, Kocagoz S, Kusoglu H, Guven T, Baran AI, Dede B, Yilmaz-Karadag F, Kose S, Yilmaz H, Aslan G, ALGallad DA, Cesur S, El-Sokkary R, Bekiroğlu N, Vahaboglu H.

Spine J. 2015 Dec 1;15(12):2509-17. doi: 10.1016/j.spinee.2015.09.024. Epub 2015 Sep 16.

PMID:
26386176
16.

The course of spinal tuberculosis (Pott disease): results of the multinational, multicentre Backbone-2 study.

Batirel A, Erdem H, Sengoz G, Pehlivanoglu F, Ramosaco E, Gülsün S, Tekin R, Mete B, Balkan II, Sevgi DY, Giannitsioti E, Fragou A, Kaya S, Cetin B, Oktenoglu T, Celik AD, Karaca B, Horasan ES, Ulug M, Senbayrak S, Kaya S, Arslanalp E, Hasbun R, Ates-Guler S, Willke A, Senol S, Inan D, Güclü E, Ertem GT, Koc MM, Tasbakan M, Ocal G, Kocagoz S, Kusoglu H, Güven T, Baran AI, Dede B, Karadag FY, Yilmaz H, Aslan G, Al-Gallad DA, Cesur S, El-Sokkary R, Sirmatel F, Savasci U, Karaahmetoglu G, Vahaboglu H.

Clin Microbiol Infect. 2015 Nov;21(11):1008.e9-1008.e18. doi: 10.1016/j.cmi.2015.07.013. Epub 2015 Jul 30.

17.

Results of a multinational study suggest the need for rapid diagnosis and early antiviral treatment at the onset of herpetic meningoencephalitis.

Erdem H, Cag Y, Ozturk-Engin D, Defres S, Kaya S, Larsen L, Poljak M, Barsic B, Argemi X, Sørensen SM, Bohr AL, Tattevin P, Gunst JD, Baštáková L, Jereb M, Johansen IS, Karabay O, Pekok AU, Sipahi OR, Chehri M, Beraud G, Shehata G, Del Vecchio RF, Maresca M, Karsen H, Sengoz G, Sunbul M, Yilmaz G, Yilmaz H, Sharif-Yakan A, Kanj SS, Parlak E, Pehlivanoglu F, Korkmaz F, Komur S, Kose S, Ulug M, Bolukcu S, Coskuner SA, Ince N, Akkoyunlu Y, Halac G, Sahin-Horasan E, Tireli H, Kilicoglu G, Al-Mahdawi A, Nemli SA, Inan A, Senbayrak S, Stahl JP, Vahaboglu H.

Antimicrob Agents Chemother. 2015;59(6):3084-9. doi: 10.1128/AAC.05016-14. Epub 2015 Mar 16.

18.

Hamsi scoring in the prediction of unfavorable outcomes from tuberculous meningitis: results of Haydarpasa-II study.

Erdem H, Ozturk-Engin D, Tireli H, Kilicoglu G, Defres S, Gulsun S, Sengoz G, Crisan A, Johansen IS, Inan A, Nechifor M, Al-Mahdawi A, Civljak R, Ozguler M, Savic B, Ceran N, Cacopardo B, Inal AS, Namiduru M, Dayan S, Kayabas U, Parlak E, Khalifa A, Kursun E, Sipahi OR, Yemisen M, Akbulut A, Bitirgen M, Popovic N, Kandemir B, Luca C, Parlak M, Stahl JP, Pehlivanoglu F, Simeon S, Ulu-Kilic A, Yasar K, Yilmaz G, Yilmaz E, Beovic B, Catroux M, Lakatos B, Sunbul M, Oncul O, Alabay S, Sahin-Horasan E, Kose S, Shehata G, Andre K, Dragovac G, Gul HC, Karakas A, Chadapaud S, Hansmann Y, Harxhi A, Kirova V, Masse-Chabredier I, Oncu S, Sener A, Tekin R, Elaldi N, Deveci O, Ozkaya HD, Karabay O, Senbayrak S, Agalar C, Vahaboglu H.

J Neurol. 2015;262(4):890-8. doi: 10.1007/s00415-015-7651-5. Epub 2015 Jan 30.

PMID:
25634680
19.

Does cerumen have a risk for transmission of HIV?

Hanege FM, Kalcioglu MT, Sargin F, Cetinkaya Z, Tekin M, Vahaboglu H.

Eur J Clin Microbiol Infect Dis. 2015 Apr;34(4):789-93. doi: 10.1007/s10096-014-2292-7. Epub 2014 Dec 6.

PMID:
25480431
20.

The features of infectious diseases departments and anti-infective practices in France and Turkey: a cross-sectional study.

Erdem H, Stahl JP, Inan A, Kilic S, Akova M, Rioux C, Pierre I, Canestri A, Haustraete E, Engin DO, Parlak E, Argemi X, Bruley D, Alp E, Greffe S, Hosoglu S, Patrat-Delon S, Heper Y, Tasbakan M, Corbin V, Hopoglu M, Balkan II, Mutlu B, Demonchy E, Yilmaz H, Fourcade C, Toko-Tchuindzie L, Kaya S, Engin A, Yalci A, Bernigaud C, Vahaboglu H, Curlier E, Akduman D, Barrelet A, Oncu S, Korten V, Usluer G, Turgut H, Sener A, Evirgen O, Elaldi N, Gorenek L.

Eur J Clin Microbiol Infect Dis. 2014 Sep;33(9):1591-9. doi: 10.1007/s10096-014-2116-9. Epub 2014 May 1.

PMID:
24789652
21.

Mortality indicators in pneumococcal meningitis: therapeutic implications.

Erdem H, Elaldi N, Öztoprak N, Sengoz G, Ak O, Kaya S, Inan A, Nayman-Alpat S, Ulu-Kilic A, Pekok AU, Gunduz A, Gozel MG, Pehlivanoglu F, Yasar K, Yılmaz H, Hatipoglu M, Cicek-Senturk G, Akcam FZ, Inkaya AC, Kazak E, Sagmak-Tartar A, Tekin R, Ozturk-Engin D, Ersoy Y, Sipahi OR, Guven T, Tuncer-Ertem G, Alabay S, Akbulut A, Balkan II, Oncul O, Cetin B, Dayan S, Ersoz G, Karakas A, Ozgunes N, Sener A, Yesilkaya A, Erturk A, Gundes S, Karabay O, Sirmatel F, Tosun S, Turhan V, Yalci A, Akkoyunlu Y, Aydın E, Diktas H, Kose S, Ulcay A, Seyman D, Savasci U, Leblebicioglu H, Vahaboglu H.

Int J Infect Dis. 2014 Feb;19:13-9. doi: 10.1016/j.ijid.2013.09.012. Epub 2013 Oct 30.

22.

Imported Plasmodium falciparum malaria in Istanbul, Turkey: risk factors for severe course and mortality.

Arslan F, Mert A, Batirel A, Inan A, Balkan II, Nazlican O, Uzun C, Vahaboglu H.

Trop Doct. 2013 Oct;43(4):129-33. doi: 10.1177/0049475513499560. Epub 2013 Sep 16.

PMID:
24043418
23.

Community-acquired CTX-M-15-type ESBL-producing Escherichia coli meningitis: a case report and literature review.

Elaldi N, Gozel MG, Kolayli F, Engin A, Celik C, Bakici MZ, Vahaboglu H.

J Infect Dev Ctries. 2013 May 13;7(5):424-31. doi: 10.3855/jidc.2820. Review.

24.

Impact of the initiation time of colistin treatment for Acinetobacter infections.

Tigen ET, Koltka EN, Dogru A, Orhon ZN, Gura M, Vahaboglu H.

J Infect Chemother. 2013 Aug;19(4):703-8. doi: 10.1007/s10156-013-0549-1. Epub 2013 Feb 8.

PMID:
23393014
25.

OXA-162, a novel variant of OXA-48 displays extended hydrolytic activity towards imipenem, meropenem and doripenem.

Kasap M, Torol S, Kolayli F, Dundar D, Vahaboglu H.

J Enzyme Inhib Med Chem. 2013 Oct;28(5):990-6. doi: 10.3109/14756366.2012.702343. Epub 2012 Jul 30.

PMID:
22845331
26.

Epidemiology and risk factors of intensive care unit-acquired infections: a prospective multicentre cohort study in a middle-income country.

Meric M, Baykara N, Aksoy S, Kol IO, Yilmaz G, Beyazit N, Mete B, Vahaboglu H.

Singapore Med J. 2012 Apr;53(4):260-3.

27.

Identification of Francisella tularensis by both culture and real-time TaqMan PCR methods from environmental water specimens in outbreak areas where tularemia cases were not previously reported.

Simşek H, Taner M, Karadenizli A, Ertek M, Vahaboğlu H.

Eur J Clin Microbiol Infect Dis. 2012 Sep;31(9):2353-7. doi: 10.1007/s10096-012-1576-z. Epub 2012 Mar 3.

PMID:
22382819
28.

Assessment of the requisites of microbiology based infectious disease training under the pressure of consultation needs.

Erdem H, Tekin-Koruk S, Koruk I, Tozlu-Keten D, Ulu-Kilic A, Oncul O, Guner R, Birengel S, Mert G, Nayman-Alpat S, Eren-Tulek N, Demirdal T, Elaldi N, Ataman-Hatipoglu C, Yilmaz E, Mete B, Kurtaran B, Ceran N, Karabay O, Inan D, Cengiz M, Sacar S, Yucesoy-Dede B, Yilmaz S, Agalar C, Bayindir Y, Alpay Y, Tosun S, Yilmaz H, Bodur H, Erdem HA, Dikici N, Dizbay M, Oncu S, Sezak N, Sari T, Sipahi OR, Uysal S, Yeniiz E, Kaya S, Ulcay A, Kurt H, Besirbellioglu BA, Vahaboglu H, Tasova Y, Usluer G, Arman D, Diktas H, Ulusoy S, Leblebicioglu H.

Ann Clin Microbiol Antimicrob. 2011 Dec 16;10:38. doi: 10.1186/1476-0711-10-38.

29.

Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis.

Ascioglu S, Leblebicioglu H, Vahaboglu H, Chan KA.

J Antimicrob Chemother. 2011 Jun;66(6):1215-22. doi: 10.1093/jac/dkr136. Epub 2011 Apr 11. Review.

PMID:
21482564
30.

Minor extended-spectrum β-lactamases.

Akinci E, Vahaboglu H.

Expert Rev Anti Infect Ther. 2010 Nov;8(11):1251-8. doi: 10.1586/eri.10.119. Review.

PMID:
21073290
31.

CTX-M type extended spectrum beta-lactamases in Escherichia coli isolates from community acquired upper urinary tract infections at a university in the European part of Turkey.

Celik AD, Yulugkural Z, Kuloglu F, Eroglu C, Torol S, Vahaboğlu H, Akata F.

J Microbiol Immunol Infect. 2010 Apr;43(2):163-7. doi: 10.1016/S1684-1182(10)60026-6.

32.

Characterization of ESBL (SHV-12) producing clinical isolate of Enterobacter aerogenes from a tertiary care hospital in Nigeria.

Kasap M, Fashae K, Torol S, Kolayli F, Budak F, Vahaboglu H.

Ann Clin Microbiol Antimicrob. 2010 Jan 12;9:1. doi: 10.1186/1476-0711-9-1.

33.

Pseudo-outbreak of Serratia marcescens in a tertiary care hospital.

Dundar D, Meric M, Vahaboglu H, Willke A.

New Microbiol. 2009 Jul;32(3):273-6.

34.

Evidence for the presence of full-length PARK2 mRNA and Parkin protein in human blood.

Kasap M, Akpinar G, Sazci A, Idrisoglu HA, Vahaboğlu H.

Neurosci Lett. 2009 Sep 4;460(3):196-200. doi: 10.1016/j.neulet.2009.05.079. Epub 2009 Jun 6.

PMID:
19501131
35.

Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey.

Elaldi N, Bodur H, Ascioglu S, Celikbas A, Ozkurt Z, Vahaboglu H, Leblebicioglu H, Yilmaz N, Engin A, Sencan M, Aydin K, Dokmetas I, Cevik MA, Dokuzoguz B, Tasyaran MA, Ozturk R, Bakir M, Uzun R.

J Infect. 2009 Mar;58(3):238-44. doi: 10.1016/j.jinf.2009.01.014. Epub 2009 Feb 26.

PMID:
19246100
36.

Water-borne Sphingomonas paucimobilis epidemic in an intensive care unit.

Meric M, Willke A, Kolayli F, Yavuz S, Vahaboglu H.

J Infect. 2009 Mar;58(3):253-5. doi: 10.1016/j.jinf.2009.01.007. Epub 2009 Feb 20. No abstract available.

PMID:
19232740
37.

Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii strains in intensive care units of multiple Mediterranean hospitals.

Giannouli M, Tomasone F, Agodi A, Vahaboglu H, Daoud Z, Triassi M, Tsakris A, Zarrilli R.

J Antimicrob Chemother. 2009 Apr;63(4):828-30. doi: 10.1093/jac/dkp032. Epub 2009 Feb 17. No abstract available.

PMID:
19223304
38.

[Comparison of quantitative hepatitis B virus DNA levels in serum and liver biopsy samples of chronic hepatitis B patients].

Rüzgar M, Cetin Akhan S, Vahaboğlu H.

Mikrobiyol Bul. 2008 Apr;42(2):283-91. Turkish.

PMID:
18697426
39.

Emergence and spread of carbapenem-resistant Acinetobacter baumannii in a tertiary care hospital in Turkey.

Meric M, Kasap M, Gacar G, Budak F, Dundar D, Kolayli F, Eroglu C, Vahaboglu H.

FEMS Microbiol Lett. 2008 May;282(2):214-8. doi: 10.1111/j.1574-6968.2008.01129.x. Epub 2008 Mar 25.

40.

Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers.

Akhan SC, Yulugkural Z, Vahaboglu H.

Chemotherapy. 2007;53(6):402-6. Epub 2007 Oct 12.

PMID:
17934260
41.

The investigation of Chlamydophila pneumoniae in patients with multiple sclerosis.

Budak F, Keçeli S, Efendi H, Budak F, Vahaboğlu H.

Int J Neurosci. 2007 Mar;117(3):409-15.

PMID:
17365124
42.

High prevalence of OXA-51-type class D beta-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: co-existence with OXA-58 in multiple centres.

Vahaboglu H, Budak F, Kasap M, Gacar G, Torol S, Karadenizli A, Kolayli F, Eroglu C.

J Antimicrob Chemother. 2006 Sep;58(3):537-42. Epub 2006 Jul 1.

PMID:
16816400
43.

The resistance of Escherichia coli strains isolated from community-acquired urinary tract infections.

Sümer Z, Coskunkan F, Vahaboglu H, Bakir M.

Adv Ther. 2005 Sep-Oct;22(5):419-23.

PMID:
16418148
44.

An outbreak of SHV-5 producing Klebsiella pneumoniae in a neonatal intensive care unit; meropenem failed to avoid fecal colonization.

Gundes S, Arisoy AE, Kolayli F, Karaali E, Turker G, Sanic A, Arisoy ES, Vahaboglu H.

New Microbiol. 2005 Jul;28(3):231-6.

PMID:
16240695
45.

Outbreak of tularaemia in Golcuk, Turkey in 2005: report of 5 cases and an overview of the literature from Turkey.

Karadenizli A, Gurcan S, Kolayli F, Vahaboglu H.

Scand J Infect Dis. 2005;37(10):712-6. Review.

PMID:
16191887
46.

Genetic and enzymatic properties of metallo-beta-lactamase VIM-5 from a clinical isolate of Enterobacter cloacae.

Gacar GG, Midilli K, Kolayli F, Ergen K, Gundes S, Hosoglu S, Karadenizli A, Vahaboglu H.

Antimicrob Agents Chemother. 2005 Oct;49(10):4400-3.

47.

PER-1 is still widespread in Turkish hospitals among Pseudomonas aeruginosa and Acinetobacter spp.

Kolayli F, Gacar G, Karadenizli A, Sanic A, Vahaboglu H; Study Group.

FEMS Microbiol Lett. 2005 Aug 15;249(2):241-5.

48.

Genetic environment and expression of the extended-spectrum beta-lactamase blaPER-1 gene in gram-negative bacteria.

Poirel L, Cabanne L, Vahaboglu H, Nordmann P.

Antimicrob Agents Chemother. 2005 May;49(5):1708-13.

49.

A critical step for relative quantification of mRNAs is selecting the correct internal controls.

Vahaboglu H.

FEMS Microbiol Lett. 2005 Apr 1;245(1):191-2. No abstract available.

50.

Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures.

Bakir M, Ugurlu M, Dokuzoguz B, Bodur H, Tasyaran MA, Vahaboglu H; Turkish CCHF Study Group.

J Med Microbiol. 2005 Apr;54(Pt 4):385-9.

PMID:
15770025

Supplemental Content

Loading ...
Support Center